Research Article

Increased Interleukin-6 Activity Associated with Painful Chemotherapy-Induced Peripheral Neuropathy in Women after Breast Cancer Treatment

Table 1

Sample Characteristics.

Demographic variableChemotherapy-induced peripheral neuropathy group ( )Comparison group ( )

Age [mean SD(range)]56.8 6.6 years (42–65)53.4 5.6 years (43–65)
Marital statusMarried12 (60%)Married11(55%)
Divorced 5 (25%)Divorced7 (35%)
Widowed3 (15%)Widowed2 (10%)
EducationHigh school11 (55%)High school10 (50%)
College 5 (25%)College 7 (35%)
Postgraduate4 (20%)Postgraduate3 (15%)
Income level $50 K/year6 (30 ) $50 K year7 (35%)
$50–74 K/year 6 (30 )$50–74 K year 6 (30%)
$75 K/year8 (40%) $75 K year 7 (35%)
Tobacco UseNever16 (80%)Never15 (75%)
Current or past use4 (20%)Current or past use5 (25%)
Comorbid conditions0 conditions7 (35%)0 conditions8 (40%)
1 condition 8 (40%)1 condition10 (50%)
2 conditions4 (20%) 2 conditions1 (5%)
3 or more conditions1 (5%)3 or more conditions1 (5%)

Independent t-tests were used to analyze demographic data. There were no significant differences between the painful CIPN and Comparison groups on any of the demographic or treatment-related variables.